A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

Many patients in trial lost an average of 16 pounds in just nine months.

Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...